BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 31780712)

  • 1. Mechanical properties of the shoulder and pectoralis major in breast cancer patients undergoing breast-conserving surgery with axillary surgery and radiotherapy.
    Lipps DB; Leonardis JM; Dess RT; McGinnis GJ; Marsh RB; Strauss JB; Hayman JA; Pierce LJ; Jagsi R
    Sci Rep; 2019 Nov; 9(1):17737. PubMed ID: 31780712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loco-regional morbidity after breast conservation and axillary lymph node dissection for early breast cancer with or without regional nodes radiotherapy, perspectives in modern breast cancer treatment: the Skagen Trial 1 is active.
    Nielsen HM; Friis RB; Linnet S; Offersen BV
    Acta Oncol; 2017 May; 56(5):713-718. PubMed ID: 28105873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for regional nodal failure after breast-conserving therapy: regional nodal irradiation reduces rate of axillary failure in patients with four or more positive lymph nodes.
    Grills IS; Kestin LL; Goldstein N; Mitchell C; Martinez A; Ingold J; Vicini FA
    Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):658-70. PubMed ID: 12788171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arm and shoulder morbidity in breast cancer patients after breast-conserving therapy versus mastectomy.
    Nesvold IL; Dahl AA; Løkkevik E; Marit Mengshoel A; Fosså SD
    Acta Oncol; 2008; 47(5):835-42. PubMed ID: 18568481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial].
    Sávolt A; Musonda P; Mátrai Z; Polgár C; Rényi-Vámos F; Rubovszky G; Kovács E; Sinkovics I; Udvarhelyi N; Török K; Kásler M; Péley G
    Orv Hetil; 2013 Dec; 154(49):1934-42. PubMed ID: 24292111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional integrity of the shoulder joint and pectoralis major following subpectoral implant breast reconstruction.
    Leonardis JM; Lyons DA; Giladi AM; Momoh AO; Lipps DB
    J Orthop Res; 2019 Jul; 37(7):1610-1619. PubMed ID: 30816589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prognosis and risk factors of 1 791 patients with breast cancer treated with breast-conserving surgery based on real-world data].
    Chen SY; Tang Y; Song YW; Wang SL; Jin J; Liu YP; Wang WH; Fang H; Ren H; Sun GY; Wang JY; Jing H; Zhang JH; Liu XF; Yu ZH; Li YX
    Zhonghua Zhong Liu Za Zhi; 2018 Aug; 40(8):619-625. PubMed ID: 30139034
    [No Abstract]   [Full Text] [Related]  

  • 8. Radiation field design and regional control in sentinel lymph node-positive breast cancer patients with omission of axillary dissection.
    Setton J; Cody H; Tan L; Morrow M; Hudis C; Catalano J; McCormick B; Powell S; Ho A
    Cancer; 2012 Apr; 118(8):1994-2003. PubMed ID: 21882186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial.
    Mansel RE; Fallowfield L; Kissin M; Goyal A; Newcombe RG; Dixon JM; Yiangou C; Horgan K; Bundred N; Monypenny I; England D; Sibbering M; Abdullah TI; Barr L; Chetty U; Sinnett DH; Fleissig A; Clarke D; Ell PJ
    J Natl Cancer Inst; 2006 May; 98(9):599-609. PubMed ID: 16670385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effectiveness of Botulinum Toxin A for treatment of upper limb impairments and dysfunctions in breast cancer survivors: A randomised controlled trial.
    De Groef A; Devoogdt N; Van Kampen M; De Hertogh L; Vergote M; Geraerts I; Dams L; Van der Gucht E; Debeer P
    Eur J Cancer Care (Engl); 2020 Jan; 29(1):e13175. PubMed ID: 31571329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical management of early stage invasive breast cancer: a practice guideline.
    McCready D; Holloway C; Shelley W; Down N; Robinson P; Sinclair S; Mirsky D; ;
    Can J Surg; 2005 Jun; 48(3):185-94. PubMed ID: 16013621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional nodal management and patterns of failure following conservative surgery and radiation therapy for stage I and II breast cancer.
    Halverson KJ; Taylor ME; Perez CA; Garcia DM; Myerson R; Philpott G; Levy J; Simpson JR; Tucker G; Rush C
    Int J Radiat Oncol Biol Phys; 1993 Jul; 26(4):593-9. PubMed ID: 8330987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term morbidity after a negative sentinel node in breast cancer patients.
    Verbelen H; Tjalma W; Meirte J; Gebruers N
    Eur J Cancer Care (Engl); 2019 Sep; 28(5):e13077. PubMed ID: 31050088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Local relapse in young (< or = 40 years) women with breast cancer after mastectomy or breast conserving surgery: 15-year results].
    Fodor J; Mózsa E; Zaka Z; Polgár C; Major T
    Magy Onkol; 2005; 49(3):203, 205-8. PubMed ID: 16249814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of axillary ultrasound (AUS) on axillary dissection in breast conserving surgery (BCS).
    Reyna C; Kiluk JV; Frelick A; Khakpour N; Laronga C; Lee MC
    J Surg Oncol; 2015 Jun; 111(7):813-8. PubMed ID: 25753101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla - Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: A randomized, single centre, phase III, non-inferiority trial.
    Sávolt Á; Péley G; Polgár C; Udvarhelyi N; Rubovszky G; Kovács E; Győrffy B; Kásler M; Mátrai Z
    Eur J Surg Oncol; 2017 Apr; 43(4):672-679. PubMed ID: 28139362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional nodal recurrence in breast cancer patients treated with conservative surgery and radiation therapy (BCS+RT).
    Pejavar S; Wilson LD; Haffty BG
    Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1320-7. PubMed ID: 17049182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repeat surgery following breast conservation and intra-operative sentinel lymph node analysis for breast cancer.
    Dabbas N; Cutress RI; Wise M; Yiangou C; Agrawal A
    Surgeon; 2013 Oct; 11(5):235-40. PubMed ID: 23453370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of the Axilla in T1-2 Breast Cancer Patients with Macrometastatic Sentinel Node Involvement Who Underwent Breast-Conserving Therapy.
    Kuru B; Yuruker S; Sullu Y; Gursel B; Ozen N
    J Invest Surg; 2019 Jan; 32(1):48-54. PubMed ID: 28945489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Second axillary sentinel node biopsy for ipsilateral breast tumour recurrence.
    Intra M; Trifirò G; Galimberti V; Gentilini O; Rotmensz N; Veronesi P
    Br J Surg; 2007 Oct; 94(10):1216-9. PubMed ID: 17583891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.